SEC 13F Intelligence

Beese Fulmer Investment Management, Inc. / EW

Beese Fulmer Investment Management, Inc.’s Edwards Lifesciences Corp Position

Does Beese Fulmer Investment Management, Inc. own Edwards Lifesciences Corp (EW)? Yes — 160.8K shares worth $13M (+0.83% of its 13F portfolio) as of Q1 2026, up from 158.8K shares the prior filed quarter.

Position Value
$13M
Q1 2026
Shares
160.8K
% of Portfolio
+0.83%
Quarters Held
30
currently held

Position History EW

Reported value by quarter
Q4 ’18: $6MQ4 ’18Q1 ’19: $7MQ2 ’19: $7MQ3 ’19: $8MQ4 ’19: $9MQ4 ’19Q1 ’20: $7MQ2 ’20: $8MQ3 ’20: $9MQ4 ’20: $11MQ4 ’20Q1 ’21: $10MQ2 ’21: $12MQ3 ’21: $13MQ4 ’21: $15MQ4 ’21Q1 ’22: $14MQ2 ’22: $11MQ3 ’22: $10MQ4 ’22: $9MQ4 ’22Q1 ’23: $10MQ2 ’23: $12MQ3 ’23: $9MQ4 ’23: $10MQ4 ’23Q1 ’24: $13MQ2 ’24: $14MQ3 ’24: $9MQ4 ’24: $10MQ4 ’24Q1 ’25: $10MQ2 ’25: $11MQ3 ’25: $12MQ4 ’25: $14MQ4 ’25Q1 ’26: $13Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026160.8K$13M+0.83%
Q4 2025158.8K$14M+0.88%
Q3 2025152.7K$12M+0.82%
Q2 2025140.7K$11M+0.82%
Q1 2025137.0K$10M+0.85%
Q4 2024135.7K$10M+0.86%
Q3 2024140.0K$9M+0.79%
Q2 2024147.9K$14M+1.24%
Q1 2024140.5K$13M+1.26%
Q4 2023135.3K$10M+1.07%
Q3 2023127.2K$9M+0.99%
Q2 2023122.0K$12M+1.25%
Q1 2023120.8K$10M+1.14%
Q4 2022117.1K$9M+1.05%
Q3 2022115.4K$10M+1.28%
Q2 2022114.9K$11M+1.40%
Q1 2022118.9K$14M+1.52%
Q4 2021117.3K$15M+1.58%
Q3 2021116.9K$13M+1.49%
Q2 2021117.3K$12M+1.37%
Q1 2021117.8K$10M+1.18%
Q4 2020116.8K$11M+1.36%
Q3 2020116.7K$9M+1.32%
Q2 2020117.1K$8M+1.19%
Q1 202038.7K$7M+1.29%
Q4 201939.4K$9M+1.29%
Q3 201938.5K$8M+1.27%
Q2 201938.9K$7M+1.36%
Q1 201939.1K$7M+1.48%
Q4 201839.0K$6M+1.35%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Beese Fulmer Investment Management, Inc.’s full portfolio or all institutional holders of EW.